These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6130024

  • 1. [Drug treatment of a trial fibrillation in patients with Wolff-Parkinson-White syndrome].
    Guaragna RF, Capucci A, Sangiorgio P, Bracchetti D.
    G Ital Cardiol; 1982; 12(4):284-91. PubMed ID: 6130024
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [An electrophysiologic and electropharmacological study of functional properties of the bundle of Kent in Wolff-Parkinson-White syndrome].
    Costantini M, Chimienti M, Zardini M, Klersy C, Guasti L, Salerno JA.
    Cardiologia; 1989 Apr; 34(4):365-74. PubMed ID: 2758442
    [Abstract] [Full Text] [Related]

  • 4. [Ventricular pre-excitation: electrophysiopathology, criteria for interpretation and clinical diagnosis. References for geriatrics].
    Tamburrini LR, Fontanelli A, Primossi G.
    Minerva Cardioangiol; 2001 Feb; 49(1):47-73. PubMed ID: 11279385
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of the anti-arrhythmia agent ethmozin on the refractory period of the accessory pathway in Wolff-Parkinson-White syndrome].
    Rakovec P, Kenda MF.
    Wien Med Wochenschr; 1986 Feb 15; 136(3):65-6. PubMed ID: 3515775
    [Abstract] [Full Text] [Related]

  • 8. [Effects of amiodarone on atrio-ventricular and ventriculo-atrial conduction in the Wolff-Parkinson-White syndrome (author's transl)].
    Disertori M, Molinis G, Vergara G, Bettini R, Furlanello F.
    G Ital Cardiol; 1976 Feb 15; 6(5):792-802. PubMed ID: 1010214
    [Abstract] [Full Text] [Related]

  • 9. Clinical presentation and treatment of atrial fibrillation in Wolff-Parkinson-White syndrome.
    Thanavaro JL, Thanavaro S.
    Heart Lung; 2010 Feb 15; 39(2):131-6. PubMed ID: 20207273
    [Abstract] [Full Text] [Related]

  • 10. Acute ventricular rate control in atrial fibrillation and atrial flutter.
    Khan IA, Nair CK, Singh N, Gowda RM, Nair RC.
    Int J Cardiol; 2004 Oct 15; 97(1):7-13. PubMed ID: 15336799
    [Abstract] [Full Text] [Related]

  • 11. Management of rapid ventricular rate in acute atrial fibrillation.
    Shettigar UR.
    Int J Clin Pharmacol Ther; 1994 May 15; 32(5):240-5. PubMed ID: 7921518
    [Abstract] [Full Text] [Related]

  • 12. [Recurrent episodes of Morgagni-Adams-Stokes syndrome due to degeneration of atrio-ventricular tachycardias into atrial fibrillation in a patient with Wolf-Parkinson-White syndrome].
    Walczak F, Biederman A, Jodkowska M, Jedynak Z, Rembelska H, Kepski R, Sliwiński M, Hoffman M.
    Kardiol Pol; 1991 May 15; 34(6):364-6. PubMed ID: 1942747
    [Abstract] [Full Text] [Related]

  • 13. Clinical and electrophysiologic characteristics in patients with Wolff-Parkinson-White pattern.
    Antunes E, da Silva N, Catarino C, Serra J, Galrinho A, Ferreira R, Quininha J, Gracias R, Rato JA.
    Rev Port Cardiol; 1993 Apr 15; 12(4):333-6. PubMed ID: 8512728
    [Abstract] [Full Text] [Related]

  • 14. Supernormal conduction in the anomalous bundles of the Wolff-Parkinson-White syndrome: an overlooked electrophysiologic property with potential clinical implications.
    Chiale PA, Albino E, Garro HA, Selva H, Levi RJ, Sánchez RA, Elizari MV, Alvarez CB.
    J Cardiovasc Pharmacol Ther; 2007 Sep 15; 12(3):181-91. PubMed ID: 17875945
    [Abstract] [Full Text] [Related]

  • 15. [The clinical features and long-term follow-up of atrial fibrillation or atrial flutter complicating Wolff-Parkinson-White syndrome].
    Wang Q, Pu S, Cai N.
    Zhonghua Nei Ke Za Zhi; 1996 Mar 15; 35(3):153-6. PubMed ID: 9387649
    [Abstract] [Full Text] [Related]

  • 16. Atrial fibrillation in the Wolff-Parkinson-White syndrome: ECG recognition and treatment in the ED.
    Fengler BT, Brady WJ, Plautz CU.
    Am J Emerg Med; 2007 Jun 15; 25(5):576-83. PubMed ID: 17543664
    [Abstract] [Full Text] [Related]

  • 17. [Wide QRS complex tachycardia: an old and new problem].
    Oreto G, Luzza F, Satullo G, Donato A, Carbone V, Calabrò MP.
    G Ital Cardiol (Rome); 2009 Sep 15; 10(9):580-95. PubMed ID: 19891250
    [Abstract] [Full Text] [Related]

  • 18. Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
    Swerdlow CD, Peterson J, Liem LB.
    Am J Cardiol; 1988 Jul 01; 62(1):78-82. PubMed ID: 2898208
    [Abstract] [Full Text] [Related]

  • 19. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
    Masotti CS, Pierangeli A.
    Panminerva Med; 1999 Dec 01; 41(4):295-306. PubMed ID: 10705709
    [Abstract] [Full Text] [Related]

  • 20. Clinical applications of antiarrhythmic drugs.
    Lavenne F, de Jonghe D.
    Acta Cardiol Suppl; 1980 Dec 01; (25):27-42. PubMed ID: 6155012
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.